These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12126721)

  • 21. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen.
    Thisyakorn U; Khongphatthanayothin M; Sirivichayakul S; Rongkavilit C; Poolcharoen W; Kunanusont C; Bien DD; Phanuphak P
    AIDS; 2000 Dec; 14(18):2921-7. PubMed ID: 11153673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
    de Souza RS; Gómez-Marín O; Scott GB; Guasti S; O'Sullivan MJ; Oliveira RH; Mitchell CD
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):154-61. PubMed ID: 10935691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
    Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Shaffer N; Chuachoowong R; Mock PA; Bhadrakom C; Siriwasin W; Young NL; Chotpitayasunondh T; Chearskul S; Roongpisuthipong A; Chinayon P; Karon J; Mastro TD; Simonds RJ
    Lancet; 1999 Mar; 353(9155):773-80. PubMed ID: 10459957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Bhadrakom C; Simonds RJ; Mei JV; Asavapiriyanont S; Sangtaweesin V; Vanprapar N; Moore KH; Young NL; Hannon WH; Mastro TD; Shaffer N
    AIDS; 2000 Mar; 14(5):509-16. PubMed ID: 10780713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors.
    Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P
    AIDS; 2003 Sep; 17(13):1889-96. PubMed ID: 12960821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
    Ojesina AI; Mullins C; Imade G; Samuels J; Sankalé JL; Pam S; Sagay S; Idoko J; Kanki PJ
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1587-92. PubMed ID: 18160018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods.
    Kuhn L; Abrams EJ; Weedon J; Lambert G; Schoenbaum EE; Nesheim SR; Palumbo P; Vink PE; Bulterys M
    J Infect Dis; 2000 Jul; 182(1):104-11. PubMed ID: 10882587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
    Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection.
    Grosch-Wörner I; Schäfer A; Obladen M; Maier RF; Seel K; Feiterna-Sperling C; Weigel R
    AIDS; 2000 Dec; 14(18):2903-11. PubMed ID: 11153672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
    Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
    East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
    AIDS; 1999 May; 13(8):927-33. PubMed ID: 10371173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.
    Ly N; Phoung V; Min DC; Srey C; Kruy LS; Koum K; Chhum V; Glaziou P; Fleury HJ; Reynes JM
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1563-8. PubMed ID: 18160014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(8):151-4. PubMed ID: 9518278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.